Groups
Company Size (Fulltime employees)
Looking for
Functionality
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Index
Countries
Reset

jun xia United States

Able Cerebral is currently apply phase III clinical study with FDA for its controlled release of brain energy product. The product has shown remarkable therapeutic effectiveness for mid-stage and early stage Alzheimer's disease.

Able Cerebral is also developing a game changing, non-invasive medical device that will consolidate and recovery of brain memory for mid-stage and late stage Alzheimer's disease.

Website:
www.ablecerebral.com
Year of foundation
2012
Looking for
Funding Status
looking for investors or partners for advance our product and programs. Able Cerebral is ready to convert to Delaware C-Corp
Headquartner in China
No
Plan in China
We were planning to engage some sci-tech park in China before the pandemic.
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Slides Deck
(pptx, 308.49KB)
able cerebral
Co-Founder / President 
Functionality
Management

Mengtao Xiao China

MNC
Website:
BI Official web
Looking for
Headquartner in China
No
Boehringer Ingelheim
Senior Manager,BD&Licensing 
Functionality
Business Development

Penghui Xie China

We are a leading CRO biotech company. We focus on antibody development.

Website:
www.abiocenter.com
Looking for
Headquartner in China
Yes
Service Description
研发工具或服务 Research tools and services
Abiocenter (Beijing) Biotechnology Co., Ltd.
CEO 
Functionality
Business Development

Dandan Xie China

Focused in genitourinary（GU）/women health field with 2 global assets for bladder cancer and pre-cervical cancer treatment in phase 3 stages，looking for in/out-licensing partnership in GU/women health area
Website:
www.asieris.cn
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
Service Description
治疗产品 Therapeutic products
Asieris Pharmaceuticals
BD Director 

John Xu United States

Bi-Specific antibody drug discovery
Website:
www.Abpro.com
Year of foundation
2004
Looking for
Please specify your partnering goal
Pre IPO fund raising
Headquartner in China
No
Plan in China
Set up subsidiary in China next year
Biotech/Pharma Category
Investment Focus
Looking for investors
Abpro
SVP 
Functionality
Business Development

Meng Xu China

Established in February 1994 with approval from the State Council, Suzhou Industrial Park (SIP) is the first governmental cooperation project between China and Singapore. Covering an administrative area of 278 sqkm, it is home to 1.19 million people, including 807,800 permanent residents. SIP focuses on three main area, Bio-medicine, AI and nanomaterials.
Over 1400 bio-medicine companies are located in SIP including Alphamab Oncology, Innovent and Cstones.
Science & technology development center provide services to entrepreneurial teams who is looking for a place to start up their business.
Website:
www.sipac.gov.cn
Looking for
Headquartner in China
Yes
Suzhou Industrial Park Administrative Committee - Science & technology development center
Science & Technology development center - staff 

Siyuan Xu China

VISEN Pharmaceuticals, headquartered in Shanghai, China, is committed to the treatment of endocrine-related disease, introducing the world’s leading treatment methods and drugs into the China market, benefiting Chinese patients while unleashing product potential.

VISEN Pharmaceuticals (VISEN) was formed by Ascendis Pharma A/S (Nasdaq: ASND) and an investor syndicate led by Vivo Capital (along with participation by Sofinnova Ventures), to develop and commercialize Ascendis Pharma’s endocrinology rare disease therapies in Greater China. The pipeline of VISEN covers pediatric endocrinology, adult endocrinology, and rare disease. VISEN management team has extensive experience in the development and commercialization of endocrine disease products in Greater China. VISEN has a deep understanding of unmet medical needs in Chinese patients and is actively expanding its pipeline through in-licensing and partnership.
Website:
www.visenpharma.com
Looking for
Headquartner in China
Yes
Biotech/Pharma Category
VISEN Pharmaceutical
Senior BD Manager 
Functionality
Business Development

Wenjie Xu United States

As China Focus conference organizer, MyBioGate is a premier cross-border healthcare consulting firm serving Biotech and Medtech clients, and the Chinese Pharma companies and investors. We offer marketing, strategy and execution support to help healthcare innovation to grow by taking advantage of China’s huge market potential. We help innovative companies with China-Landing services, and help them find reliable Chinese investors and partners. MyBioGate is committed to linking healthcare innovations in China and overseas. We share global healthcare innovation, entrepreneurship, investment trends, KOL opinions, important events and conferences, in-depth research and analysis, allowing Chinese medical and health companies and investors to gain insight into trends and seize investment opportunities. Our China Focus forums, Global Healthcare Innovation Competitions, and road shows to China provide innovative companies who intend to enter China market with platforms for exposure to potential investors and partners.

Website:
https://en.mybiogate.com/
Mybiogate Inc.
Investment Manager